Determinants of disability and quality of life in mild to moderate Parkinson disease
Abstract
Objective: To identify factors that independently contribute to disability and quality of life (QoL) in patients with mild to moderate Parkinson disease (PD).
Methods: A group of 190 patients with PD recruited from outpatient clinics and the Dutch Parkinson’s Disease Association participated in this cross-sectional study. Data on demographic and clinical factors, motor symptoms, cognitive functions, affective symptoms, comorbidity, and social support were collected during neurologic and neuropsychological examinations. Disability was rated using the Schwab and England Activities of Daily Living Scale (SE-ADL), the AMC Linear Disability Score (ALDS), and the Functional Independence Measure (FIM). QoL was assessed with the Parkinson’s Disease Quality of Life questionnaire (PDQL) and the Medical Outcome Study Short Form (SF-36). Multiple linear regression analyses were conducted to identify determinants of disability and poor QoL.
Results: Axial impairment (postural instability and gait difficulty) explained the largest proportion of variance in disability. Bradykinesia and comorbidity contributed to disability, but to a lesser extent. Self-reported mood symptoms and axial impairment were the two factors most closely associated with poorer QoL, but comorbidity and bradykinesia additionally contributed to the explanatory power. Semantic fluency and psychomotor skills were the only cognitive variables related to some aspects of functional outcome.
Conclusion: Axial impairment is strongly associated with disability in patients with mild to moderate Parkinson disease (PD). Self-report indices of mood status and axial impairment are identified as the main determinants of poor quality of life (QoL). The results of this study may help to identify patients with PD at risk for functional dependence and reduced QoL.
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
REFERENCES
1.
Marras C, Rochon P, Lang AE. Predicting motor decline and disability in Parkinson disease. A systematic review. Arch Neurol 2002;59:1724–1728.
2.
Post B, Merkus MP, de Haan RJ, Speelman JD. CARPA Study Group. Prognostic factors for the progression of Parkinson’s disease: A systematic review. Mov Disord 2007;22:1839–1851.
3.
Maeshima S, Itakura T, Nakagava M, Kunio N, Norihiko K. Visuospatial impairment and activities of daily living in patients with Parkinson’s disease. Am J Phys Med Rehabil 1997;76:383–388.
4.
Bronnick K, Ehrt U, Emre M, et al. Attentional deficits affect activities of daily living in dementia-associated with Parkinson’s disease. J Neurol Neurosurg Psychiatry 2006;77:1136–1142.
5.
Cahn D, Sullivan EV, Shear PK, Pfefferbaum A, Heit G, Silverberg G. Differential contributions of cognitive and motor component processes to physical and instrumental activities of daily living in Parkinson’s disease. Arch Clin Neuropsychol 1998;13:575–583.
6.
Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD. Visual dysfunction in Parkinson disease. Neurology 2005;65:1907–1913.
7.
Martinez-Martin P, Deutschl G. Effect of medical and surgical interventions on health-related quality of life in Parkinson’s disease. Mov Disord 2007;6:757–765.
8.
Schrag A, Jahanshahi M, Quinn N. How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000;15:1112–1118.
9.
Schrag A. Quality of life and depression in Parkinson’s disease. J Neurol Sci 2006;248:151–157.
10.
Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson’s disease. Neurology 2005;65:1239–1245.
11.
Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33–39.
12.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427–442.
13.
Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968;16:622–626.
14.
De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003;56:221–229.
15.
Fahn S, Elton RI, and members of the UP, DRS Development Committee. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Development in Parkinson’s Disease. Vol. 2. Florham Park, NJ: Macmillan Health Care Information; 1987:153–163.
16.
Levy G, Tang MX, Cote LJ, et al. Motor impairment in PD: relationship to incident dementia and age. Neurology 2000;55:539–544.
17.
Kang GA, Bronstein JM, Masterman DL, Redelings M, Crum JA, Ritz B. Clinical characteristics in early Parkinson’s disease in a central California population-based study. Mov Disord 2005;20:1133–1142.
18.
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
19.
Schmand B, Lindeboom J, van Harskamp F. [Dutch Adult Reading Test.] Lisse, The Netherlands: Swets and Zeitlinger; 1992.
20.
Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment, 4th ed. New York: Oxford University Press; 2004.
21.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–370.
22.
Marinus J, Leentjens AFG, Visser M, Stiggelbout AM, van Hilten JJ. Evaluation of the Hospital Anxiety and Depression Scale in patients with Parkinson’s disease. Clin Neuropharmacol 2002;25:318–324.
23.
Feij JA, Doorn CD, van Kampen D, van den Berg PT, Resing WCM. Sensation seeking and social support as moderators of the relationship between life events and physical illness/psychological distress. In: Winnubst JAM, Maes S, eds. Lifestyles Stress and Health. Leiden: DSWO Press; 1992:285–302.
24.
Schwab JF, England AC. Projection technique for evaluating surgery in Parkinson’s disease. In: Gillingham FJ, Donaldson MC, eds. Third symposium on Parkinson’s disease. Edinburgh: E&S Livingstone; 1969:152–157.
25.
Lindeboom R, Vermeulen M, Holman R, de Haan RJ. Activities of daily living instruments: optimizing scales for neurologic assessment. Neurology 2003;60:738–742.
26.
Holman R, Weisscher N, Glas CAW, et al. The Academic Medical Center Linear Disability Score (ALDS) item bank: item response theory analysis in a mixed patient population. Health Qual Life Outcomes 2005;3:83.
27.
Keith RA, Granger CV, Hamilton BB, Sherwin FS. The Functional Independence Measure: a new tool for rehabilitation. In: Eisenberg MG, Grzesiak RC, eds. Advances in Clinical Rehabilitation. Vol. 2. New York: Springer; 1987:6–18.
28.
Weisscher N, Post B, de Haan RJ, Glas CA, Speelman JD, Vermeulen M. The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease. Neurology 2007;69:2155–2161.
29.
Kidd D, Stewart G, Baldry J, et al. The functional independence measure: a comparative validity and reliability study. Disabil Rehabil 1995;17:10–14.
30.
De Boer AGEM, Wijker W, Speelman JD, et al. Quality of life in patients with Parkinson’s disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996;61:70–74.
31.
McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form heath survey (SF-36): II: psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247–263.
32.
Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM. Health related quality of life in Parkinson’s disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry 2002;72:241–248.
33.
Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43–46.
34.
Esselink RAJ, de Bie RMA, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology 2004;62:201–207.
35.
Karlsen KH, Larsen JP, Tandberg E, Maeland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 1999;66:431–435.
36.
Schrag A. Psychiatric aspects of Parkinson’s disease: an update. J Neurol 2004;251:795–804.
37.
Brooks DJ. Imaging non-dopaminergic function in Parkinson’s disease. Mol Imaging Biol 2007;9:217–222.
38.
Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson’s disease. J Am Geriatr Soc 2004;52:784–788.
39.
Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson’s disease? J Neurol Neurosurg Psychiatry 2000;69:308–312.
40.
Lyons KE, Pahwa R, Troester AE. A comparison of Parkinson’s disease symptoms and self- reported functioning and well being. Parkinsonism Relat Disord 1997;4:207–209.
Information & Authors
Information
Published In
Copyright
© 2008.
Publication History
Published online: June 2, 2008
Published in print: June 3, 2008
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Determinants of patient-reported functional mobility in people with Parkinson's disease: A systematic review, Gait & Posture, 108, (97-109), (2024).https://doi.org/10.1016/j.gaitpost.2023.11.013
- Episode-level prediction of freezing of gait based on wearable inertial signals using a deep neural network model, Biomedical Signal Processing and Control, 88, (105613), (2024).https://doi.org/10.1016/j.bspc.2023.105613
- Rehabilitation for non-motor symptoms for patients with Parkinson’s disease from an α-synuclein perspective: a narrative review, Exploration of Neuroprotective Therapy, (235-257), (2023).https://doi.org/10.37349/ent.2023.00049
- Effects of stochastic resonance whole-body vibration on sensorimotor function in elderly individuals—A systematic review, Frontiers in Sports and Active Living, 5, (2023).https://doi.org/10.3389/fspor.2023.1083617
- Quality of life: Seasonal fluctuation in Parkinson's disease, Frontiers in Neurology, 13, (2023).https://doi.org/10.3389/fneur.2022.1035721
- Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease, Journal of Parkinson's Disease, 13, 1, (49-55), (2023).https://doi.org/10.3233/JPD-223501
- Gender differences in motor and non-motor symptoms in individuals with mild-moderate Parkinson’s disease, PLOS ONE, 18, 1, (e0272952), (2023).https://doi.org/10.1371/journal.pone.0272952
- Kinect-based objective evaluation of bradykinesia in patients with Parkinson's disease, DIGITAL HEALTH, 9, (205520762311766), (2023).https://doi.org/10.1177/20552076231176653
- Effects of training involving patterned sensory enhancement on improving upper-limb movements in patients with Parkinson’s disease: protocol of a randomised controlled trial, BMJ Open, 13, 7, (e072416), (2023).https://doi.org/10.1136/bmjopen-2023-072416
- undefined, 2023 IEEE 13th International Conference on CYBER Technology in Automation, Control, and Intelligent Systems (CYBER), (962-967), (2023).https://doi.org/10.1109/CYBER59472.2023.10256589
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to get full access to it.